Related Insights

Healthcare investors discuss navigating the downcycle

 
Jonathan Norris

How to raise startup funds in a tough market — according to a life science investor

 
Barbara Alcaraz Silva

Corporate investors remain key pillars of life sciences and healthcare

 
Ariana Ognibene, Jonathan Norris

Top life science investment trends for early-stage startups

 
Ben Johnson

A founder's persistence in therapeutics

 
Barbara Alcaraz Silva

SVB's 2022 healthtech report reveals strong investment opportunity in mental health

 
Christopher Moniz

About the Author

Tracy Isacke is head of the vendor transformation office for Silicon Valley Bank. She and her team are responsible for third-party risk management, as well as building relationships with the bank’s most strategic vendors and partners to provide SVB employees with development opportunities, policy information, training, tools, support and guidance to most effectively support business partners across the organization.

Tracy joined SVB in 2014 to develop key corporate innovation partnerships and programs to connect bank clients to potential partners and investors. Before joining SVB, Tracy was an executive vice president, new business ventures, at Telefónica Digital, where she identified investment opportunities in Silicon Valley, Israel and Europe with the potential to accelerate Telefónica’s business. She also led an international global partner team to deliver unique partnerships and direct-to-bill opportunities for Telefónica across 25 operating businesses in Europe and Latin America.

Tracy started her career at Xerox, rising to be one of the first female members of the UK board of directors. Following her work at Xerox, she spent four years with an early-stage, venture-backed startup that went on to achieve a successful exit.

Born in the UK, Tracy has lived in Italy, Israel and California. She lives in Scottsdale, Arizona, with her husband and family.